| UniProt ID | PLBL2_HUMAN | |
|---|---|---|
| UniProt AC | Q8NHP8 | |
| Protein Name | Putative phospholipase B-like 2 | |
| Gene Name | PLBD2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 589 | |
| Subcellular Localization | Lysosome lumen . | |
| Protein Description | Putative phospholipase.. | |
| Protein Sequence | MVGQMYCYPGSHLARALTRALALALVLALLVGPFLSGLAGAIPAPGGRWARDGQVPPASRSRSVLLDVSAGQLLMVDGRHPDAVAWANLTNAIRETGWAFLELGTSGQYNDSLQAYAAGVVEAAVSEELIYMHWMNTVVNYCGPFEYEVGYCERLKSFLEANLEWMQEEMESNPDSPYWHQVRLTLLQLKGLEDSYEGRVSFPAGKFTIKPLGFLLLQLSGDLEDLELALNKTKIKPSLGSGSCSALIKLLPGQSDLLVAHNTWNNYQHMLRVIKKYWLQFREGPWGDYPLVPGNKLVFSSYPGTIFSCDDFYILGSGLVTLETTIGNKNPALWKYVRPRGCVLEWVRNIVANRLASDGATWADIFKRFNSGTYNNQWMIVDYKAFIPGGPSPGSRVLTILEQIPGMVVVADKTSELYQKTYWASYNIPSFETVFNASGLQALVAQYGDWFSYDGSPRAQIFRRNQSLVQDMDSMVRLMRYNDFLHDPLSLCKACNPQPNGENAISARSDLNPANGSYPFQALRQRSHGGIDVKVTSMSLARILSLLAASGPTWDQVPPFQWSTSPFSGLLHMGQPDLWKFAPVKVSWD | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 18 | Phosphorylation | SHLARALTRALALAL HHHHHHHHHHHHHHH | 16.95 | - | |
| 36 | Phosphorylation | LLVGPFLSGLAGAIP HHHHHHHHHHHCCCC | 31.94 | - | |
| 59 | Ubiquitination | DGQVPPASRSRSVLL CCCCCCCCCCCCEEE | 36.24 | 21963094 | |
| 65 | Ubiquitination | ASRSRSVLLDVSAGQ CCCCCCEEEEECCCC | 3.40 | 21963094 | |
| 75 | Ubiquitination | VSAGQLLMVDGRHPD ECCCCEEEECCCCCC | 3.34 | 27667366 | |
| 81 | Ubiquitination | LMVDGRHPDAVAWAN EEECCCCCCHHHHHH | 29.87 | 27667366 | |
| 88 | N-linked_Glycosylation | PDAVAWANLTNAIRE CCHHHHHHHHHHHHH | 36.38 | 17105447 | |
| 110 | N-linked_Glycosylation | LGTSGQYNDSLQAYA CCCCCCCCHHHHHHH | 25.22 | 17105447 | |
| 190 | Ubiquitination | RLTLLQLKGLEDSYE HHHHHHHCCCCCCCC | 48.79 | - | |
| 190 | Ubiquitination | RLTLLQLKGLEDSYE HHHHHHHCCCCCCCC | 48.79 | 21906983 | |
| 206 | Ubiquitination | RVSFPAGKFTIKPLG CCCCCCCCEEECCHH | 41.25 | 27667366 | |
| 208 | Phosphorylation | SFPAGKFTIKPLGFL CCCCCCEEECCHHHH | 31.42 | - | |
| 231 | N-linked_Glycosylation | EDLELALNKTKIKPS HHHHHHHHCCCCCCC | 44.32 | 17105447 | |
| 234 | Ubiquitination | ELALNKTKIKPSLGS HHHHHCCCCCCCCCC | 50.79 | 29967540 | |
| 236 | Ubiquitination | ALNKTKIKPSLGSGS HHHCCCCCCCCCCCC | 30.06 | 22817900 | |
| 242 | Ubiquitination | IKPSLGSGSCSALIK CCCCCCCCCHHHHHH | 30.76 | 22817900 | |
| 253 | Ubiquitination | ALIKLLPGQSDLLVA HHHHHCCCCCCEEEE | 39.32 | 23503661 | |
| 255 | Phosphorylation | IKLLPGQSDLLVAHN HHHCCCCCCEEEEEC | 35.82 | - | |
| 259 | Ubiquitination | PGQSDLLVAHNTWNN CCCCCEEEEECCCCC | 7.09 | 23503661 | |
| 267 | Phosphorylation | AHNTWNNYQHMLRVI EECCCCCHHHHHHHH | 9.15 | - | |
| 354 | Methylation | VRNIVANRLASDGAT HHHHHHHHHHCCCCC | 23.15 | 115487739 | |
| 357 | Phosphorylation | IVANRLASDGATWAD HHHHHHHCCCCCHHH | 40.96 | - | |
| 367 | Ubiquitination | ATWADIFKRFNSGTY CCHHHHHHHHHCCCC | 57.31 | - | |
| 367 | Ubiquitination | ATWADIFKRFNSGTY CCHHHHHHHHHCCCC | 57.31 | 22817900 | |
| 371 (in isoform 2) | Phosphorylation | - | 29.78 | 26437602 | |
| 373 (in isoform 2) | Phosphorylation | - | 23.93 | 26437602 | |
| 374 | Phosphorylation | KRFNSGTYNNQWMIV HHHHCCCCCCEEEEE | 18.68 | 19413330 | |
| 384 | Ubiquitination | QWMIVDYKAFIPGGP EEEEEEEEEECCCCC | 32.15 | 23503661 | |
| 392 | Phosphorylation | AFIPGGPSPGSRVLT EECCCCCCCCHHHHH | 45.21 | 19413330 | |
| 395 | Phosphorylation | PGGPSPGSRVLTILE CCCCCCCHHHHHHHH | 23.70 | 19413330 | |
| 407 | Sulfoxidation | ILEQIPGMVVVADKT HHHHCCCEEEEEECC | 1.41 | 21406390 | |
| 436 | N-linked_Glycosylation | PSFETVFNASGLQAL CCHHEECCHHHHHHH | 28.94 | 17105447 | |
| 465 | N-linked_Glycosylation | RAQIFRRNQSLVQDM HHHHHHCCHHHHHCH | 31.38 | 17105447 | |
| 467 | Phosphorylation | QIFRRNQSLVQDMDS HHHHCCHHHHHCHHH | 33.77 | - | |
| 474 | Phosphorylation | SLVQDMDSMVRLMRY HHHHCHHHHHHHHHH | 16.73 | - | |
| 515 | N-linked_Glycosylation | RSDLNPANGSYPFQA CCCCCCCCCCCCHHH | 41.00 | 17105447 | |
| 517 | O-linked_Glycosylation | DLNPANGSYPFQALR CCCCCCCCCCHHHHH | 29.46 | 28657654 | |
| 545 | Phosphorylation | MSLARILSLLAASGP HHHHHHHHHHHHHCC | 20.97 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PLBL2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PLBL2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PLBL2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| WDHD1_HUMAN | WDHD1 | physical | 22939629 | |
| RBM12_HUMAN | RBM12 | physical | 22939629 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-465, AND MASSSPECTROMETRY. | |
| "Biochemical characterization and lysosomal localization of themannose-6-phosphate protein p76 (hypothetical protein LOC196463)."; Jensen A.G., Chemali M., Chapel A., Kieffer-Jaquinod S., Jadot M.,Garin J., Journet A.; Biochem. J. 402:449-458(2007). Cited for: PROTEIN SEQUENCE OF 42-49 AND 244-250, GLYCOSYLATION AT ASN-88;ASN-110; ASN-231; ASN-436; ASN-465 AND ASN-515, INTERACTION WITHIGF2R, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND MASSSPECTROMETRY. | |